index - Myasthenia Gravis: étiologie, physiopathologie & approches thérapeutiques

Dernières publications

Chargement de la page

Chiffres clés

Chargement de la page

Open Access

Chargement de la page

Mots clés

Interféron de type I Early-onset myasthenia gravis Immune regulation Chemokine Puberty Interferon type I Thymoma Il-23 Immune response Thymectomy Thymus Exercise Interferon IFN Interferon type-I Disease susceptibility Clinical cell transplantation Adaptive immunity Interferonopathy Follicular hyperplasia Endogenous nucleic acids Assay comparison Long-term follow-up LMNA Interleukine-23 Experimental autoimmune myasthenia gravis Experimental models Ferrites Interferon Acides nucléiques endogènes Cardiomyopathy Etiology Immunity Interleukin 23 Myoblasts Genetics DICER Myasthenia Gravis Human myoblasts Th17 cells Experimental autoimmune myasthenia gravis EAMG Cytokines Fragile X syndromes MG patients Complete Freund's adjuvant FMR1 Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype Quality of life Germinal center Thymic epithelial cells Acetylcholine receptor antibodies Chronic inflammation Autoimmune disease Interferon-β Auto-immunité Ectopic germinal centers Animal models PBMC Heart failure Gd T cells Chronicity CCL21 Inflammation Genetic associations Autoimmune diseases Immunotherapy CXCL13-CXCR5 Acetylcholine receptor Experimental mouse models Interferon de type I Neuromuscular junction COX2 Myasthenia Gravis MG Inflammatory cytokines Cellules th17 Antimir-150 B cells Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration AChR antibodies BAFF Innate immunity COVID-19 Cell-cell communication CD31 Conduction disease Myasthenia gravis Immunology and Microbiology Section M3243AG Chemokines Myasthénie grave Acetylcholine receptors Gender Germinal centers Autoimmunity Lamin A/C nuclei Glucocorticoids Centres germinatifs ectopiques Anticorps monoclonal Transcriptome Age CTCF